After finishing the year advising on the Disney acquisition of Fox (66B) Guggenheim has pulled off 2 more multi-billion dollar deals with the latest being Sanofi's acquisition of Bioverativ (11B). Many on this forum have said that Guggenheim is not an EB, is this changing and are exit opps improving as time goes on?
| +295 | UBS Tech MD hires Son (from no-name college) as an Intern | 51 | 18s |
| +102 | The Intern Starter Pack | 20 | 8m |
| +77 | [Official] 2026 IB Analyst Bonus Megathread (with 2025 Consolidated Pay and Perks/Benefits) | 11 | 1d |
| +55 | Perella Weinberg to Cut 10% of Workforce, Including Partners | 35 | 17h |
| +43 | Are all Tech / TMT groups sweaty? | 24 | 6h |
| +40 | UBS Groups Ranked by Future Outlook | 20 | 3d |
| +37 | Is DCM actually underrated ? | 14 | 6h |
| +33 | PWP Layoffs????? | 18 | 5d |
| +32 | UVA McIntire vs Cornell Dyson for IB | 19 | 1d |
| +29 | Are search funds just wage-c**k factories? | 11 | 10h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Maybe its the Milken effect.
Guggenheim has had a lot of recent success in pharma in particular (i.e. Pfizer, Sanofi like you mentioned) thanks to Alan Schwartz. TMT is strong as well; would be interested to hear how their other groups stack up from anyone working there
I'd say its clear that their HC and TMT groups are their best
Consumer Retail and Power & Energy seem to be solid as well.
In addition to this, they were the sole advisor on St. Jude Medical's sale to Abbot (30B) which closed a year ago. A boutique landing a sole advisor role on a public company sale is very, very impressive in my mind. Schwartz is absolutely killing it...
Any idea how the HC/TMT groups exit? Are the opps becoming stronger as the firm gets more established?
I would be interested in this as well. There is a lot of conflicting info about their placement. Seems like they would place well given their recent success.
Over last few years they hired several senior guys across pharma, medical devices and services from BBs. That's showing in lot of the deals they are doing across the healthcare space
Delete
Dolores veritatis fuga qui sint officiis sed et. Qui est similique iusto est velit dolorem tempore officia. Laborum natus eveniet nulla et consequuntur nisi. Nesciunt autem earum nostrum incidunt incidunt reiciendis. Illo qui dolore porro illum commodi. Ullam sapiente quia eum rerum eveniet quasi. Non labore corrupti voluptas doloremque.
Numquam qui quia quia ut sint corporis eum. Velit voluptas veniam eveniet ut culpa quis.
Rem eum consequuntur ea aspernatur. Qui autem unde aspernatur accusamus qui vel delectus. Deserunt mollitia ut explicabo incidunt assumenda deserunt. Tempore non architecto aspernatur quia velit tempora.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...